Nortran Pharmaceutical -NRT.V Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jon Smith who wrote (359)	4/4/1998 3:27:00 PM
From: ASHLEY5	Read Replies (1) of 1185

Based on discussions with James King Investor Relations I don't think there is much doubt that a licensing deal is forthcoming very soon albeit he did not (and cannot) unequivocally state this. There is just no way the VSE would ask them to issue the release they did the other day unless something was imminent. The widespread purchasing and Maedel's newsletter all but confirm the deal is going to happen and very soon. At that time the stock will run to just about $3.75 - $4.00 and then settle back a bit until Phase 2 trials near completion. This coming week is going to prove very interesting. The IR people are downplaying the activity because they want a big move once the news is released.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next